Methyl 5-bromo-4-fluoro-2-methylbenzoate, 97%, 100mg

5-(Trifluoromethyl)benzo-[2,1,3]-thiadiazole, 95.0%, 25g

4'-Methoxyacetophenone, 99.0%, 100g

tert-Butyl (1R*,4R*)-4-(2-fluorobenzylamino)cyclohexylcarbamate, 1g

(2E)-3-(2-methoxyphenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

7-Bromo-1H-pyrazolo[3,4-c]pyridine, 95.0%, 1g

1-(4-(Trifluoromethyl)phenyl)butane-1,3-dione, 98.0%, 500mg

2-hydroxy-3-(4-methylphenyl)prop-2-enoic acid, 98%, 10g

Methyl 3-Bromo-4-methylbenzoate>98.0%(GC)5g

3-Cyanophenylacetic acid, 95.0%, 100g

2,3:4,6-bis-O-(1-methylethylidene)-α-L-xylo-2-Hexulofuranosonic acid hydrate (1:1), 97%, 100g

Benzaldehyde, min. 99.5%, for synthesis, 500 ml, glass packaging

4-(2-(4-Morpholinophenylamino)pyrimidin-4-yl)benzoic acid, 98%, 250mg